What is the market doing?
What the tape says about ADMA
ADMA Biologics, Inc. is −42% over the past year while the S&P 500 is +23%: 65 points behind the market. Through the fall, its own insiders bought $310K more stock than they sold.
−42%
1-year return · S&P 500 +23%
- vs 200-day average
- −27%
vs 200-day average · a clear downtrend
- RSI (14)
- 43
RSI (14) · neutral
- Below its 52-week high
- −53%
Below its 52-week high
Details›
- Last close2026-08-26
- $9.64
- 1 monthS&P 500 +3.7%
- +15%
- 1 yearS&P 500 +23%
- −42%
- 5 yearsS&P 500 +87%
- +506%
- vs 50-day average$8.85
- +9.0%
- 52-week high
- $20.38
- 52-week low
- $7.60
- Annualised volatility
- 62%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- $310K
| Year | Return |
|---|---|
| 2026 (year to date) | −47% |
| 2025 | +6.4% |
| 2024 | +279% |
| 2023 | +16% |
| 2022 | +175% |
| 2021 | −28% |
| 2020 | −51% |
| 2019 | +67% |
| 2018 | −26% |
| 2017 | −37% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 5 of 10 | +5.4% |
| Feb | 10 | 6 of 10 | +1.1% |
| Mar | 10 | 5 of 10 | +0.38% |
| Apr | 10 | 8 of 10 | +7.1% |
| May | 10 | 5 of 10 | +2.2% |
| Jun | 10 | 2 of 10 | −3.8% |
| Jul | 11 | 8 of 11 | +11% |
| Aug | 11 | 4 of 11 | +1.3% |
| Sep | 10 | 2 of 10 | −2.6% |
| Oct | 10 | 4 of 10 | −5.6% |
| Nov | 10 | 7 of 10 | +10% |
| Dec | 10 | 4 of 10 | −5.1% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.